Considering hormone replacement therapy (HRT) after a diagnosis of triple-negative breast cancer (TNBC) and BRCA2 mutation, especially after a mastectomy and bilateral oophorectomy, is a complex decision. Here are some key points from your knowledge base:

- Risk Factors: If you've had a diagnosis of breast cancer or tested Show Full Answer

Considering hormone replacement therapy (HRT) after a diagnosis of triple-negative breast cancer (TNBC) and BRCA2 mutation, especially after a mastectomy and bilateral oophorectomy, is a complex decision. Here are some key points from your knowledge base:

- Risk Factors: If you've had a diagnosis of breast cancer or tested positive for a breast cancer gene (like BRCA2), your doctor will likely not prescribe HRT due to increased risks.
- HRT and Breast Cancer: Combined HRT (estrogen and progestin) is associated with a higher risk of breast cancer, particularly estrogen-receptor-positive and HER2-positive cancers.
- Alternatives: There are non-hormonal ways to manage menopausal symptoms, such as:
- Limiting caffeine and alcohol
- Practicing relaxation techniques
- Maintaining a healthy weight and exercising
- Considering non-hormonal medications or local hormone therapies (like creams)

It's crucial to discuss your specific situation with your doctor to weigh the pros and cons and explore safer alternatives.

 This AI-generated response comes from MyBCTeam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

Hormone Replacement Therapy After Menopause and Breast Cancer Risk | MyBCTeam

Side Effects of Hormone Treatment for Breast Cancer | MyBCTeam